Mounjarixyl

$84.00

Drug Class: GLP-1 and GIP Receptor Agonist
Main Active Substance: Tirzepatide
Concentration: 5 mg per 2 mL vial
Presentation: 2 mL Vial
Elimination Half-Life: Approximately 5 days
Recommended Dosage: Start with 2.5 mg weekly; increase to 5 mg weekly based on response
Anabolic Ratio: N/A (Not an anabolic compound)
Androgenic Ratio: N/A (Not an androgenic compound)
Acne: None
Hepatotoxicity: None
Aromatization: None
Manufacturer: Kalpa Pharmaceuticals, India

Category: